Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:50
2388.00
3.25 (0.14%)
VOLUME 2,672
LIVE
NSE
Oct 19, 19:45
2373.05
-12.35 (-0.52%)
VOLUME 47,303
Announcements on Dr Reddys Labs

16th-Oct-2017 18:26Source: BSE

Dr Reddys Laboratories- Press Release / Media Release

Please find enclosed a Press Release on ''Dr. Reddy''s to release Q2 FY18 results on October 31, 2017 Earnings call slated for October 31, 6.30 PM IST / 9.00 AM EDT''.

12th-Oct-2017 13:25Source: BSE

Dr Reddys Labs- Allotment of ESOP / ESPS

This is to inform you that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 7,987 equity shares of Rs.5/- each of the Company, fully paid up, o...

9th-Oct-2017 19:05Source: BSE

Dr Reddys Labs- Half Yearly Compliance Certificate Issued By Company Secretary In Practice For The Period April 1, 2017 To September 30, 2017 Under Regulation 40(9) Of SEBI LODR

Half yearly compliance certificate issued by company secretary in practice for the period April 1, 2017 to September 30, 2017 under Regulation 40(9) of SEBI LODR

5th-Oct-2017 17:46Source: BSE

Dr Reddys Labs- Notice Of Board Meeting To Be Held On October 31, 2017

Notice of Board Meeting to be held on October 31, 2017

5th-Oct-2017 17:42Source: BSE

Dr Reddys Labs- Compliance Certificate Under Regulation 7(3)

Compliance certificate under Regulation 7(3)

5th-Oct-2017 17:40Source: BSE

Dr Reddys Labs- Statement Of Investor Complaints For September 30, 2017 Under Regulation 13(3)

Statement of investor complaints for September 30, 2017 under Regulation 13(3)

5th-Oct-2017 11:39Source: BSE

Dr Reddys Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011 for Dr Reddys Holdings Ltd

5th-Oct-2017 11:38Source: BSE

Dr Reddys Labs- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Reddys Holdings Ltd

5th-Oct-2017 11:03Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Holdings Ltd has submitted to the Exchange, vide letter dated October 05, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantia...

3rd-Oct-2017 16:07Source: BSE

Dr Reddys Labs- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Satish Reddy

1 2 3 4 5 Next >>
Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2017-10-31

Quarterly Results

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.